What they were paid
GYRE THERAPEUTICS Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $56,000 | — | $156,236 | — | $212,236 |
| FY2024 | $38,870 | — | $388,146 | — | $427,016 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GYRE THERAPEUTICS, INC. DEF 14A filed April 27, 2026, accession 0001140361-26-017124, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025GYRE THERAPEUTICS pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation
The rest of the GYRE THERAPEUTICS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Dan Weng, M.D | Independent Director | $383,050 |
| Gordon Carmichael, Ph.D | Independent Director | $208,236 |
| Ping Zhang | Chair of the Board | $0 |
| Renate Parry, Ph.D | Independent Director | $219,236 |
| Rodney Nussbaum | Independent Director | $214,236 |
| Songjiang Ma | Director | $0 |
| Thomas Eastling | Independent Director | $206,236 |
The full GYRE THERAPEUTICS compensation record
free company briefThis page is one director within GYRE THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat